Bactiguard Holding AB (CHIX:BACTBS) Construction In Progress: kr0.0 Mil (As of Mar. 2026)


CHIX:BACTBS Bactiguard Holding AB CHIX:BACTBS
52 GF Score
Price kr128.60
GF Value kr264.39
! 3 Warning Signs
View Full Analysis

What is Bactiguard Holding AB Construction In Progress?

Bactiguard Holding AB CHIX:BACTBS 52 Construction In Progress is kr0.0 Mil as of Mar. 2026. GuruFocus rates CHIX:BACTBS with a GF Score™ of 52/100 and a GF Value™ of kr264.39. The stock has 3 warning signs investors should review.

Bactiguard Holding AB Construction In Progress Historical Data

* Premium members only.

The historical data trend for Bactiguard Holding AB's Construction In Progress can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bactiguard Holding AB Construction In Progress Chart

Bactiguard Holding AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Construction In Progress
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Bactiguard Holding AB Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Construction In Progress Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
CHIX:BACTBS
52GF Score
Bactiguard Holding AB CHIX:BACTBS
Construction In Progress is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Bactiguard Holding AB Construction In Progress Calculation

It records the cost of construction work, which is not yet completed (typically, applied to capital budget items). A construction in progress item is not depreciated until the asset is placed in service. Normally, upon completion, a construction in progress item is reclassified, and the reclassified asset is capitalized and depreciated.

What does a Construction In Progress of kr0.0 Mil mean?
Bactiguard Holding AB (CHIX:BACTBS) has a Construction In Progress of kr0.0 Mil as of Mar. 2026. Construction in Progress records the amount of construction work that is not complete. View historical data on Bactiguard Holding AB and its competitors.
Is Bactiguard Holding AB's Construction In Progress too high?
Bactiguard Holding AB's current Construction In Progress is kr0.0 Mil. Overall, Bactiguard Holding AB has a GF Score™ of 52/100, reflecting its overall financial health beyond just this single metric.
How does Bactiguard Holding AB's Construction In Progress compare to ABT and SYK?
Bactiguard Holding AB's Construction In Progress of kr0.0 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Construction In Progress for a Medical Devices & Instruments company?
A good Construction In Progress depends on the Medical Devices & Instruments industry context. However, Construction In Progress should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Construction In Progress mean?
A high Construction In Progress can signal that a stock is expensive relative to its fundamentals. Construction in Progress records the amount of construction work that is not complete. View historical data on Bactiguard Holding AB and its competitors. Bactiguard Holding AB's current Construction In Progress is kr0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bactiguard Holding AB stock overvalued right now?
Bactiguard Holding AB (CHIX:BACTBS) has a current Construction In Progress of kr0.0 Mil. The stock's GF Value™ is kr264.39, compared to a current price of kr128.60 — trading 51.4% below its estimated fair value. The current Construction In Progress is kr0.0 Mil. Bactiguard Holding AB's overall GF Score™ is 52/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Construction In Progress calculated?
Construction In Progress is calculated from a company's financial statements. For Bactiguard Holding AB (CHIX:BACTBS), the current Construction In Progress is kr0.0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Bactiguard Holding AB (CHIX:BACTBS) Overvalued in 2026?

Based on GuruFocus' analysis, Bactiguard Holding AB stock appears to be undervalued. The current stock price of kr128.60 is trading 51.4% below its estimated GF Value™ of kr264.39.

Key valuation signals for CHIX:BACTBS:

  • Construction In Progress: kr0.0 Mil
  • GF Value™: kr264.39 vs. price of kr128.60 (51.4% below fair value)
  • GF Score™: 52/100 with 3 warning signs

No single metric tells the full story. See the CHIX:BACTBS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Bactiguard Holding AB Business Description

Other Exchanges BACTI B:Sweden5JE:Germany
Address Vasagatan 11, Stockholm, SWE, 111 20
Bactiguard Holding AB is a medical device company. It is engaged in a MedTech company developing safe and biocompatible technology to prevent medical device-related infections. The technology is based on an ultra-thin noble metal coating that prevents bacterial adhesion and biofilm formation on medical devices. The company focuses on five strategic therapeutic areas wherein infection rates create high medical needs for infection prevention. These areas include Orthopedics, Cardiology, Neurology, Urology, and Vascular Access. Geographically, the company operates in the USA, Malaysia, China, Saudi Arabia, Bangladesh, Sweden, the Czech Republic, and Other countries. The majority of its revenue is generated from the USA region.
52GF Score

Get the complete analysis for CHIX:BACTBS

Construction In Progress is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr128.60
Price
kr264.39
GF Value